Perbedaan Hotel Fitra International Tbk. dan Organon Pharma Indonesia Tbk.: Hotel Fitra International Tbk. diperdagangkan di Rp454 (kapitalisasi pasar 555,62 M, volume 24 jam 3,15 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Hotel Fitra International Tbk. jauh lebih besar — sekitar 5,3× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| FITT | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 555,62 M | 104,4 M |
Volume | 3,15 jt | — |
Lot | 31,5 rb | — |
Perputaran | 1,45 M | — |
Harga Rata-rata | 461,26 | — |
Nilai Transaksi | 1,45 M | — |
Harga Ekuilibrium Indikatif | 454 | — |
Volume Ekuilibrium Indikatif | 262 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Hotel Fitra International Tbk ("the Company") was established based on deed No. 34 dated January 24, 2014 of Muhammad Hanafi, S.H., notary in Jakarta.
Selengkapnya di halaman FITT →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →